Modified RNAi agents
One aspect of the present invention relates to double-stranded RNAi (dsRNA) duplex agent capable of inhibiting the expression of a target gene. The dsRNA duplex comprises one or more motifs of three identical modifications on three consecutive nucleotides in one or both strand, particularly at or ne...
Gespeichert in:
Hauptverfasser: | , , , , , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | One aspect of the present invention relates to double-stranded RNAi (dsRNA) duplex agent capable of inhibiting the expression of a target gene. The dsRNA duplex comprises one or more motifs of three identical modifications on three consecutive nucleotides in one or both strand, particularly at or near the cleavage site of the strand. Other aspects of the invention relates to pharmaceutical compositions comprising the dsRNA agents suitable for therapeutic use, and methods of inhibiting the expression of a target gene by administering the dsRNA agents, e.g., for the treatment of various diseaseconditions.
本发明的个方面涉及能够抑制种靶基因的表达的双链RNAi(dsRNA)双链体试剂。该dsRNA双链体在条或两条链中包括个或多个在三个连续核苷酸上具有三个相同修饰的基序,特别是在该链的裂解位点处或附近。本发明的其他方面涉及包括这些适于治疗用途的dsRNA试剂的药物组合物以及通过给予这些dsRNA试剂来抑制种靶基因的表达的方法,例如用于治疗各种疾病病症。 |
---|